Organizing Committee
OCM Member
Edith Cowan University , Australia
Biography :

Short Biography Ian James Martins is an Editor/Reviewer for Open Acess Pub/MDPI journals/other international journals. He is Advisory Board Member for Photon Journal. He is a Fellow of the International Agency for Standards and Ratings (IASR). He conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. He is Chief Editor for International Journal of Diabetes Research (2014-2019), Research and Reviews: Neuroscience (2016-2019) and Journal of Diabetes and Clinical Studies (2017-2019). He is BIT Member (BIT Congress. Inc) with an H-index of 65 and Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu with citations >4800. Researchgate Analysis: RG score (>96%) of international Scientists. He acquired 71 International Certificates. He is a reviewer for approx. 47 journals over the past five years. Now he is in the 98th percentile as assessed for Publons users by merit. He is Advisory Committee and Organizing Board Member for various international conferences (2018-2019).

Research Interest :

Worked with PFIZER LTD., Lyka Labs Ranbaxy (now Sun Pharma) & Cancer Research Institute Mumbai. Now working as "Quality by Design /cGMP consultant" " Quality Expert " " Quality Adviser"to many institutions like Emerson Process Management , World Bank, PwC & many Indian Cos. Specialized in "Quality by Design" implementation in Formulations / API- R&D and Mfg.

OCM Member
General Manager Technical Operations
SURGE Laboratories Private Limited , Pakistan
Biography :

Rashid Mahmood has a Master Degree in Analytical Chemistry and an MS in Total Quality Management. He has 15 years of experience in Pharmaceutical Quality Operations and has attended many international conferences as a keynote speaker. He has presented various talks in USA, Canada, UK and UAE on Cleaning Validation, cGMP Guidelines, Quality Risk Management, Role of Mass Spectrometry in Pharmaceuticals and on new Drug Delivery Systems. Currently, he is working as a General Manager Technical Operations for Surge Lab. (Manufacturer of Microencapsulated APIs, Liquid & Dry Powder Parentrals) which is the best export-oriented organization of Pakistan.

Research Interest :

Worked with PFIZER LTD., Lyka Labs Ranbaxy (now Sun Pharma) & Cancer Research Institute Mumbai. Now working as "Quality by Design /cGMP consultant" " Quality Expert " " Quality Adviser"to many institutions like Emerson Process Management , World Bank, PwC & many Indian Cos. Specialized in "Quality by Design" implementation in Formulations / API- R&D and Mfg.

OCM Member
Quality by Design /cGMP consultant
"Instituto de Assistência Médica ao Servidor Público Estadual" (IAMSPE) , Brazil
Biography :

In a career span of 49 years, have rich & varied experience in the Pharmaceutical Industry, especially in Quality Management, R&D, and Regulatory.

Research Interest :

Worked with PFIZER LTD., Lyka Labs Ranbaxy (now Sun Pharma) & Cancer Research Institute Mumbai. Now working as "Quality by Design /cGMP consultant" " Quality Expert " " Quality Adviser"to many institutions like Emerson Process Management , World Bank, PwC & many Indian Cos. Specialized in "Quality by Design" implementation in Formulations / API- R&D and Mfg.

OCM Member
Principal
Ramchandra Chandravansi University, Jharkhand. , India
Biography :

Dr. Md. Faiyazuddin is a renowned Edupreneurs, academician & researcher with expertise in the field of Pharmaceutical Nanotechnology. Currently, he is the Principal at Tetri Chandravansi Pharmacy College, Ramchandra Chandravansi University, Jharkhand. He is the Founder President- International Pharma Forum, and Global Business Director (Asia region) at Nano Drug Delivery®, Baltimore MD, USA.

Research Interest :

Nanoplatform for potential molecules for lungs delivery, preparation and characterization of targetspecific drug delivery systems for gastrointestinal tract infections, oral delivery of cytotoxic drugs for solid tumors in novel biodegradable polymeric nanoparticles, nanocarriers for skin delivery, herbal nanoconjugates for hepatoprotection.

OCM Member
Emeritus Scientist
National Chemical Laboratory , India
Biography :

Microbial Culture Isolation & Preservation ? Microbial Technology & Fermentation Production of enzymes such as cellulases, xylanases, lipases, pectinases, hydantoinases, Citric acid and lactic acid fermentations. Biomass conversion to value added products such as ethanol and lactic acid. ? Microbial Strain Improvement Cellulase, ethanol and lactic acid producing strains were improved using traditional approaches such as mutations, protoplast fusion in bacteria, yeast and fungi. ? Bio-transformations ? Chemoenzymatic process for chiral amino acids such as phenyl glycine, ? Process for prostaglandin intermediate using isolated yeast strain. Licensed to Hygeia Laboratory. ? Transesterifications using lipases. Achievements ? Fellow of Biotech Research Society of India (BRSI) ? Member of American Chemical Society ? Published over 80 papers in reputed international journals. ? Indian Patents: 4 ? US Patents: 6

Research Interest :

Biochemistry

OCM Member
CEO
RegenerAge Clinic , Mexico
Biography :

Dr. Osorio is a innovative businessman with an distinct entrepreneurial mindset concentrated in adding value on the areas of Biotechnology (mRNA), Reprogramming & Regenerative Medicine for translational use in humans and a variety of clinical applications aimed for both the private and the public health sectors. He is the CEO of RegenerAge Clinic and RegenerAge Beauty. VP and Clinical Developer for Bioquark, Inc., CCO at Reanima Advance Biosciences Project. President at Dr. Jois an anti-aging, beauty, and cosmetic products endorsement company. VP and Chairman of the WAMS Americas Division. Earned MD degree at Westhill University. Diplomate in aesthetic medicine (UAG), Advance Fellow by the ABAARM, visiting scholar at UNC at Chapel Hill in Dermatology. Fellow in Stem Cell Medicine by the A4M and USF, Business Diplomate at ECA, enrolled Master on Health Sciences at Victoria University. Has appeared on several occasions on International media, some of his latest broadcast appearances are CNN español, TV Azteca, Excelsior Newspaper, Medicable, PharmaBoard Room, and Podcasts among others. His public appearances as a speaker at the 2018 RAADfest (San Diego), 3rd International Conference on Molecular Medicine and Diagnostics (Dubai), Global Academic Business Forum on Tissue Engineering and Regenerative Medicine (Baltimore), Second International Congress on mHealth (Shiraz), 6th International Conference on Tissue Engineering and Regenerative Medicine (S.F), 11th World Congress on Cell & Tissue Science (Tokyo), 17th International Conference on Neurology and Neuroscience (Toronto), 9th International Conference & Exhibition on Tissue Science and Regenerative Medicine (Las Vegas) among others, makes him a pioneer on the Regenerative+Reprogramming Medicine Field. His passion for football, brought as a result the Dr.Jois Foundation A.C aimed at helping those American football athletes who have sustained injury get another chance through the Regenerative & Reprogramming Medicine.

Research Interest :

Regenerative Medicine

OCM Member
Industrie pharma , France
Biography :

Dr. Carolle-Laure KPOUMIE has worked as pediatric assistant physician in pediatric’s department of faculty of medicine in Cameroon, as clinical researcher methodology, scientific writing, public health, oncology, internal medicine and continued her career in pharmaceutical industries in France. She participates in many congress with studies made in hospitals on relevant cases in the framework Studies and clinical research. She became head of department, director, head of district where she continued her research, writing of treatment protocols in different departments for common pathologies encountered in her context, managing Epidemic crisis such as cholera, meningitis, avian influenza, yellow fever and organizes campaigns on infectious diseases ,HIV, cardiovascular diseases, family planning, research on severe malaria, malnutrition in Children and participates in studies on neonatal mortality in underdeveloped countries. She work on ADR in hospital following drug administration, pharmacovigilance, vaccinovigilance, biovigilance, materiovigilance, pharmacovigilance in underdeveloped countries, articles, medical information and therapeutic safety, clinical trials, Post-marketing, and other’s studies.

Research Interest :

Drug Safety

OCM Member
President/CEO and Professor , Gynecology
International Institute of Medicine and Science, Inc. , USA
Biography :

Dr. Alain L Fymat is a medical-physical scientist and an educator. He is the current President/CEO and Professor at the International Institute of Medicine and Science with a previous appointment as Executive Vice President, Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine. He was educated at the University of Paris-Sorbonne and the University of California at Los Angeles. He was formerly Professor of Radiology, Radiological Sciences, Radiation Medicine (Oncology), Critical Care Medicine, and Physics at several U.S. and European Universities. Previously, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs, Veterans Health Administration (Office of Research Oversight), and Director of the Magnetic Resonance Imaging Center and for a time Acting Chair of Radiology at its Loma Linda, California Medical Center. He has extensively published (~ 425 publications including patents, books & monographs, book chapters, refereed articles). As invited/keynote speaker and member of organizing committees of international congresses and symposia, he has lectured extensively across the USA, Canada, Europe, Africa and Asia. He has been the recipient of numerous research grants from government, academia and private industry, and has consulted extensively with these entities. He is a Board member of several institutions and Health Advisor of the American Heart & Stroke Association (Coachella Valley Division, California). He is Editor-in-Chief, Honorable Editor or Editor of 35 medical-scientific Journals. He published more than 37 articles in different journals.

Research Interest :

Interface between science and medicine, particularly nanomedicine, nanobiotechnology, cancer/oncology, molecular/personal/precision medicine, human genetics/ epigenetics/ ecogenetics, neurodegenerative diseases, and pharmacogenomics, nanotechnology and cancer, nanochemotherapy, nanoneurology, natural and synthetic immunotherapy, drug delivery across the brain protective barriers, and neurodegenerative disorders (epilepsy, Parkinson's and Alzheimer's diseases).

OCM Member
Head of the laboratory
Russian Academy of Sciences , Russia
Biography :

Linnikov Oleg Dmitrievich, Head of Research laboratory, Institute of Solid State Chemistry, Ural Branch of the Russian Academy of Sciences (RAS), Ekaterinburg, Russia. Education: Ural. Poly. Inst., Ekaterinburg, Russia, diploma (hon.), Institute of Solid State Chemistry, Ural Branch of the Russian Academy of Sciences (RAS), Ekaterinburg, PhD, 1996; Doctor of Sciences (Physical Chemistry), 2012 (the Russian Doctor of Science degree is the highest research degree in this country).

OCM Member
Professor, Department of Chemistry
Tokyo University of Science , Japan
Biography :

Takashiro AKITSU, Ph.D. is a full Professor for the Department of Chemistry, Faculty of Science Division II at Tokyo University of Science. He completed his undergraduate school training (chemistry) from Osaka University, Japan and his graduate school training (physical & inorganic chemistry, especially coordination, crystal, and bioinorganic chemistry) from Osaka University (Ph.D. 2000). After Keio University and Stanford University, He moved to the current affiliation since 2008. Dr. Akitsu has published up to about 180 articles in peer-reviewed journals and has had posters presented at international level. He has been a peer reviewer of many journals and acted as an organizing committee of several international conferences.

OCM Member
CEO
WAMS(The World Academy of Medical Sciences) , Mexico
Biography :

Mr. De la Parra is an entrepreneur focused on Information Technology, Education and Health. He is creative and results-driven and has 16+ years of Digital Strategy experience in architecture and implementation. Mr. De la Parra is the COO and Co-founding Partner at The Solomon Brokerage Firm. He currently leads as CEO at Mass Media Division & De la Parra Mobile Solutions, while also being the President of PetroM Renewable, VP of Operations & Strategy at PetroM Logistics, both divisions of PetroM Corp. Former COO & Co-founder at RegenerAge® Clinic & RegenerAge® Beauty & a member of the Board of Advisors. Former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil, former Digital Strategy Director & Co-founder at Dr. Jois®, BiorganicAging®, What Skin Needs™/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former CMO at ReAnima Advanced Biosciences and former Digital Media Director at Bioquark, Inc. Within the academic and educational fields, Mr. De la Parra acted as the Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, a member of the WAMS Executive Council (WAMS Executive Board), a member of the WAMS Education & Training Board (ETB), a member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & is also a Senior Partner at WAMS, The World Academy of Medical Sciences. He is also an Advisory Board member, functioned as the Chief Operating Officer and is a Co-founding Partner at The Reprogramming Medicine Association. Mr. De la Parra is also a member of the National Introducing Brokers Association and a part of the National Biofuel Board, (Alliance Program), also being the founder and former Board of Directors member of Astrum Fundación, an Advisory Board member of the Lifeboat Foundation, an Advisory Board member of the Future Worlds Center - Cyprus Neuroscience & Technology Institute (Senior TV Program), a Federated member of the International Longevity Alliance, and volunteered as Digital Strategy adviser at the Major Mouse Testing Program. He is also a member of the Web Committee at the Life Extension Advocacy Foundation / Lifespan.io and has volunteered with SENS Research Foundation for the OncoSENS Program in Digital Strategy. Alejandro De la Parra Solomon is on Google+, Facebook, and on LinkedIn.

OCM Member
Kazan national research technical university , Russia
Biography :

Vitaly Ovchinnikov has completed his PhD at the age of 26 years from University of Kazan (Russia). He is professor at Kazan national research technical university (KNITU-KAI). He has published more than 100 papers in reputed journals.

Allied Academies Global Conference Directory

Mail us at

Program Enquiry
connect@conferencesmeet.com
Sponsorship Opportunity
globalpharma@alliedglobalevents.com
Whatsapp Enquiry
enquire@conferencesmeet.com
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility

Delegates are personally responsible for their belongings at the venue. The Organizers will not be held responsible for any stolen or missing items belonging to Delegates, Speakers or Attendees; due to any reason whatsoever.


Insurance

Registration fees do not include insurance of any kind.


Transportation

Please note that any (or) all transportation and parking is the responsibility of the registrant.


Press/Media

Press permission must be obtained from Allied Academies Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied academies are a non-profit organization. This conference is not associated with any commercial meeting company.


Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference. Once your registration is complete, please contact globalpharma@alliedglobalevents.com to request a personalized letter of invitation.

Regarding refunds, all bank charges will be for the registrant's account.

Cancellation, Postponement and Transfer of Registration

All cancellations or modifications of registration must be made in writing to Program Manager (globalpharma@alliedglobalevents.com)


Cancellation Policy.:

 

All cancellations or modifications of registration must be made in writing to finance@alliedacademies.com

If due to any reason, Allied Academies postpone an event on the scheduled date, the participant is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within the period of one year from the date of rescheduling.

Our policy has been updated on October 1st, 2018.


Postponement

If Allied Academies postpone an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies Conferences event which must occur within one year from the date of postponement.


Transfer of registration

All fully paid registrations are transferable to other persons from the same organization if registered person is unable to attend the event. Transfers must be made by the registered person in writing to Program Manager. Details must be included with the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied Academies if the person is unable to attend one of the conferences.

However, Registration cannot be transferred if it is intimated within 14 days of the respective conference.

The transferred registrations will not be eligible for Refund.



Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied Academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied Academies, including the inability to obtain a visa.


Refund Policy

If the registrant is unable to attend and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs:


  • Before 60 days of the conference: Eligible for Full Refund less $100 Service Fee
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.


Accommodation Cancellation Policy

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied Academies will advise the cancellation policy of your accommodation provider, prior to cancelling or amending your booking, to ensure you are fully aware of any non-refundable deposits.

Authorization Policy

Copyright © 2020-2021 Allied Academies, All Rights Reserved.